Skip to main content
. 2021 Nov 28;9(12):1785. doi: 10.3390/biomedicines9121785

Figure 5.

Figure 5

Summary of thioridazine’s anti-tumor mechanism of action. Key: VEGF, Vascular endothelial growth factor; PI3/AKT, phosphoinositide-3-kinase–protein kinase B/Akt HIF-1a, Hypoxia-inducible factor-1a; WNT, Wingless and Int-1; mTOR, Mammalian target of rapamycin; CDK2, Cyclin-dependent kinase 2; FAK, Focal adhesion kinase; ROS, Reactive oxygen species.